1,245
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Novel ophthalmic timolol meleate liposomal-hydrogel and its improved local glaucomatous therapeutic effect in vivo

, , , &
Pages 502-510 | Received 29 Sep 2010, Accepted 27 May 2011, Published online: 26 Jul 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Engy A Abdel Azim, Seham A Elkheshen, Rania M Hathout, Marwa A Fouly & Nada M El Hoffy. (2022) Augmented in vitro and in vivo Profiles of Brimonidine Tartrate Using Gelatinized-Core Liposomes. International Journal of Nanomedicine 17, pages 2753-2776.
Read now
Abhishek K. Sah & Preeti K. Suresh. (2017) Medical management of glaucoma: focus on ophthalmologic drug delivery systems of timolol maleate. Artificial Cells, Nanomedicine, and Biotechnology 45:3, pages 448-459.
Read now
A. Alinaghi, M. R. Rouini, F. Johari Daha & H. R. Moghimi. (2013) Hydrogel-embeded vesicles, as a novel approach for prolonged release and delivery of liposome, in vitro and in vivo. Journal of Liposome Research 23:3, pages 235-243.
Read now

Articles from other publishers (10)

Ali bigdeli, Behzad Sharif Makhmalzadeh, Mostafa Feghhi & Emad SoleimaniBiatiani. (2022) Cationic liposomes as promising vehicles for timolol/brimonidine combination ocular delivery in glaucoma: formulation development and in vitro/in vivo evaluation. Drug Delivery and Translational Research 13:4, pages 1035-1047.
Crossref
Antonio Maria Fea, Cristina Novarese, Paolo Caselgrandi & Giacomo Boscia. (2022) Glaucoma Treatment and Hydrogel: Current Insights and State of the Art. Gels 8:8, pages 510.
Crossref
Yaru Wang & Changhong Wang. (2022) Novel Eye Drop Delivery Systems: Advance on Formulation Design Strategies Targeting Anterior and Posterior Segments of the Eye. Pharmaceutics 14:6, pages 1150.
Crossref
Jagpreet kour, Neha Kumari & Bharti Sapra. (2021) Ocular prodrugs: Attributes and challenges. Asian Journal of Pharmaceutical Sciences 16:2, pages 175-191.
Crossref
Brunella Grassiri, Ylenia Zambito & Andreas Bernkop-Schnürch. (2021) Strategies to prolong the residence time of drug delivery systems on ocular surface. Advances in Colloid and Interface Science 288, pages 102342.
Crossref
Radwa M. A. Abd-Elal, Ghada H. Elosaily, Shadeed Gad, El-Sayed Khafagy & Yasser Mostafa. (2019) Full Factorial Design, Optimization, In vitro and Ex vivo Studies of Ocular Timolol-Loaded Microsponges. Journal of Pharmaceutical Innovation 15:4, pages 651-663.
Crossref
Abhishek K. Sah, Nagendra Bhuwane, Ishwari Choudhary, Shweta Ramkar & Preeti K. Suresh. 2020. Nanoformulations in Human Health. Nanoformulations in Human Health 207 226 .
Shiju Xu & Xueqin An. (2019) Preparation, microstructure and function for injectable liposome-hydrogels. Colloids and Surfaces A: Physicochemical and Engineering Aspects 560, pages 20-25.
Crossref
Xiumei Gai, Lizhen Cheng, Ting Li, Dandan Liu, Yanyan Wang, Tuanjie Wang, Weisan Pan & Xinggang Yang. (2017) In vitro and In vivo Studies on a Novel Bioadhesive Colloidal System: Cationic Liposomes of Ibuprofen. AAPS PharmSciTech 19:2, pages 700-709.
Crossref
Erin LavikMarkus H. KuehnAndrew J. ShoffstallKristyn AtkinsAlina V. DumitrescuYoung H. Kwon. (2016) Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection. Journal of Ocular Pharmacology and Therapeutics 32:10, pages 642-649.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.